Healthcare ❯ Pharmaceuticals

Drug Approval

FDA Regulatory Agencies Clinical Trials FDA Regulations Alzheimer's Disease NHS Policies NHS Antipsychotic Medications Public Health Eli Lilly Nasal Spray Imdelltra FDA Drug Approval Xolair Cardiovascular Health Regulations Guidelines TGA NHS Treatments Infant Medicine Insurance Coverage Biotechnology Esketamine FDA Approval Blood Disorder Treatment China FDA Processes Weight Management Bristol Myers Squibb

FDA Approves Weekly Leqembi Autoinjector for At-Home Maintenance in Early Alzheimer’s

Safety monitoring requirements remain in place following recent FDA warnings on ARIA.

FDA Expands Wegovy to Treat MASH as Novo Nordisk Halves Uninsured Ozempic Price

MHRA Licenses Teplizumab to Delay Onset of Type 1 Diabetes

EU Backs First Twice-Yearly Injectable for HIV Prevention

EMA Committee Recommends EU Approval for First Oral Postpartum Depression Treatment

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

UK Regulator Approves First Non-Hormonal Pill for Menopausal Hot Flushes

Swissmedic Approves First Malaria Treatment for Newborns Under 4.5 kg

Mary Catchpole Becomes First in Europe to Receive Targeted APDS Therapy

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection

NICE Poised to Reject NHS Coverage for Breakthrough Alzheimer’s Drugs

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

NHS Adds Linzagolix as New At-Home Endometriosis Treatment

NHS Approves First Daily Pill for Endometriosis Treatment

FDA Approves First Standalone Nasal Spray for Treatment-Resistant Depression

FDA Approves First Nasal Spray for Treatment-Resistant Depression

FDA Approves First New Schizophrenia Drug in Decades

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Biogen Raises 2024 Profit Forecast Following Strong Q2 Earnings

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea